DK0778780T3 - Kapselpolysaccharidimmunmodulator - Google Patents

Kapselpolysaccharidimmunmodulator

Info

Publication number
DK0778780T3
DK0778780T3 DK95932380T DK95932380T DK0778780T3 DK 0778780 T3 DK0778780 T3 DK 0778780T3 DK 95932380 T DK95932380 T DK 95932380T DK 95932380 T DK95932380 T DK 95932380T DK 0778780 T3 DK0778780 T3 DK 0778780T3
Authority
DK
Denmark
Prior art keywords
immune modulator
methods
capsule polysaccharide
abscess formation
products
Prior art date
Application number
DK95932380T
Other languages
Danish (da)
English (en)
Inventor
Dennis L Kasper
Arthur O Tzianabos
Andrew B Onderdonk
Original Assignee
Brigham & Womens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/301,271 external-priority patent/US5679654A/en
Application filed by Brigham & Womens Hospital filed Critical Brigham & Womens Hospital
Application granted granted Critical
Publication of DK0778780T3 publication Critical patent/DK0778780T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0216—Bacteriodetes, e.g. Bacteroides, Ornithobacter, Porphyromonas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/114—Fusobacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/831—Drug, bio-affecting and body treating compositions involving capsular polysaccharide of bacterium, e.g. polyribosyl ribitol phosphate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK95932380T 1994-09-02 1995-09-01 Kapselpolysaccharidimmunmodulator DK0778780T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/301,271 US5679654A (en) 1994-09-02 1994-09-02 Capsular polysaccharide immunomodulator
US08/502,865 US5700787A (en) 1994-09-02 1995-07-14 Capsular polysaccharide immunomodulator

Publications (1)

Publication Number Publication Date
DK0778780T3 true DK0778780T3 (da) 2006-04-03

Family

ID=26972264

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95932380T DK0778780T3 (da) 1994-09-02 1995-09-01 Kapselpolysaccharidimmunmodulator

Country Status (9)

Country Link
US (1) US5700787A (fr)
EP (2) EP0778780B1 (fr)
JP (2) JP4076580B2 (fr)
AT (1) ATE310534T1 (fr)
CA (1) CA2197563C (fr)
DE (1) DE69534631T2 (fr)
DK (1) DK0778780T3 (fr)
ES (1) ES2255063T3 (fr)
WO (1) WO1996007427A1 (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6241995B1 (en) * 1997-08-08 2001-06-05 University Of Saskatchewan Polygala senega compositions and methods of use
US6756361B1 (en) * 1997-10-14 2004-06-29 Nabi Enterococcus antigens and vaccines
CA2361572A1 (fr) * 1999-02-04 2000-08-10 Genzyme Corporation Prevention de la formation d'abces
CN1362880A (zh) * 1999-04-02 2002-08-07 布赖汉姆妇女医院 免疫调制聚合物
AU2005201963B2 (en) * 1999-04-02 2010-04-22 The Brigham And Women's Hospital, Inc. Immunomodulating polymers
EP1459757A1 (fr) * 1999-04-02 2004-09-22 The Brigham And Women's Hospital, Inc. Polymères immunomodulateurs
US7083777B1 (en) * 1999-04-02 2006-08-01 The Brigham And Women's Hospital, Inc. Immunomodulating polymers
WO2000059490A2 (fr) * 1999-04-06 2000-10-12 Genzyme Corporation Compositions immunomodulatrices et procedes d'utilisation
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
SV2003000753A (es) * 2000-12-05 2003-06-16 Brigham & Womens Hospital Uso de polisacaridos zwitterionicos para la especifica modulacion del progreso inmunologico
WO2003077863A2 (fr) * 2002-03-13 2003-09-25 The Brigham And Women's Hospital, Inc. Procede de surexpression de polysaccharides zwitterioniques
US7186725B2 (en) * 2003-01-03 2007-03-06 Genzyme Corporation Anti-inflammatory compositions and methods
EP1638581A2 (fr) * 2003-03-31 2006-03-29 The Brigham And Women's Hospital, Inc. Immunomodulateurs zwitterioniques destines au traitement de l'asthme et des allergies
US8206726B2 (en) 2006-02-06 2012-06-26 The Brigham And Women's Hospital, Inc. Zwitterionic polysaccharides for promotion of immune system maturation and health
US20110002965A1 (en) * 2007-11-09 2011-01-06 Round June L Immunomodulating compounds and related compositions and methods
JP2011503104A (ja) 2007-11-09 2011-01-27 カリフォルニア インスティテュート オブ テクノロジー 免疫調節化合物ならびに関連組成物および方法
US20100275282A1 (en) * 2009-04-23 2010-10-28 Round June L Methods and systems for identifying immunomodulatory substances
US8580278B2 (en) 2009-06-03 2013-11-12 Trustees Of Dartmouth College Nutraceutical composition and methods for preventing or treating multiple sclerosis
US20100311686A1 (en) * 2009-06-03 2010-12-09 Kasper Lloyd H Nutraceutical composition and methods for preventing or treating multiple sclerosis
ES2694100T3 (es) 2010-04-07 2018-12-18 California Institute Of Technology Vehículo para distribuir un compuesto en una membrana mucosa y composiciones, procedimientos y sistemas relacionados
WO2011146910A1 (fr) 2010-05-20 2011-11-24 Round June L Treg spécifiques d'un antigène et compositions, procédés et systèmes associés
WO2011151941A1 (fr) 2010-06-04 2011-12-08 国立大学法人東京大学 Composition présentant une activité d'induction de la prolifération ou de l'accumulation de cellule t régulatrice
WO2012154072A1 (fr) * 2011-05-06 2012-11-15 Aparin Petr Gennadievich Exopolysaccharide de la bactérie shigella sonnei, son procédé de production, vaccin et composition pharmaceutique le contenant
WO2013009945A1 (fr) * 2011-07-12 2013-01-17 The Brigham And Women's Hospital, Inc. Compositions de psa contenant des lipides, procédés d'isolement et procédés pour les utiliser
EP3978598B1 (fr) 2011-12-01 2024-08-28 The University of Tokyo Bactéries d'origine humaine qui induisent la prolifération ou l'accumulation de lymphocytes t régulateurs
EP2994161B1 (fr) 2013-05-10 2020-10-28 California Institute of Technology Prévention et traitement probiotiques du cancer du côlon
US11331335B2 (en) * 2015-06-10 2022-05-17 California Institute Of Technology Sepsis treatment and related compositions methods and systems
WO2017031431A1 (fr) 2015-08-19 2017-02-23 President And Fellows Of Harvard College Compositions de psa lipidés et procédés associés
EP3484441A4 (fr) 2016-07-15 2020-03-18 President and Fellows of Harvard College Compositions de glycolipide et procédés d'utilisation
CN109481472A (zh) * 2017-09-11 2019-03-19 广州知易生物科技有限公司 脆弱拟杆菌提取物在制备防治炎症性肠病的药物或食品中的应用
MA54074A (fr) * 2018-11-02 2022-02-09 4D Pharma Res Ltd Compositions comprenant des souches bactériennes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0504202B1 (fr) * 1989-12-14 1995-05-03 National Research Council Of Canada Vaccin conjugue ameliore a base de polysaccharide de meningocoque
GB2286193A (en) * 1991-03-28 1995-08-09 Italfarmaco Spa Anticoagulants and processes for preparing such

Also Published As

Publication number Publication date
AU3543995A (en) 1996-03-27
JP4076580B2 (ja) 2008-04-16
ES2255063T3 (es) 2006-06-16
EP0778780A1 (fr) 1997-06-18
WO1996007427A1 (fr) 1996-03-14
AU702325B2 (en) 1999-02-18
DE69534631T2 (de) 2006-08-17
ATE310534T1 (de) 2005-12-15
CA2197563C (fr) 2010-07-20
CA2197563A1 (fr) 1996-03-14
JP2008094851A (ja) 2008-04-24
EP0778780B1 (fr) 2005-11-23
DE69534631D1 (de) 2005-12-29
JPH10507746A (ja) 1998-07-28
EP1637158A2 (fr) 2006-03-22
US5700787A (en) 1997-12-23
EP1637158A3 (fr) 2006-04-05

Similar Documents

Publication Publication Date Title
DK0778780T3 (da) Kapselpolysaccharidimmunmodulator
IT1219942B (it) Esteri polisaccaridici
FI973279A (fi) Uudet farnesyylitransferaasin inhibiittorit, niiden valmistus ja niitä sisältävät farmaseuttiset koostumukset
OA09776A (en) "Improved vaccine compositions".
MX9704030A (es) 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos.
ES557735A0 (es) Procedimiento para preparar peptidos difluorcetonicos
MY114786A (en) Vaccines
PT763037E (pt) Derivados de pirrol ¬a|-anelizados e sua utilizacao farmaceutica
NO972391L (no) 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav
BG102106A (en) Phermaceutical composition containing proteinase inhibitor and monoglyceride
DE58902712D1 (de) N-acetylglucosamin-zubereitungen zur buccalen anwendung.
AU2894389A (en) Novel preparation and method of use thereof
DK0406745T3 (da) Antibiotiske GE 2270 faktorer A1, A2, A3 og H
GR3015899T3 (en) Antibiotic GE 2270 factors B1, B2, C1, C2, D1, D2,E and T.
FR2708855B1 (fr) Compositions pharmaceutiques immunoadjuvantes ou immunostimulantes.
MX9704035A (es) 1,1-dioxidos de 2-(fosfiniloximetil)-1,2,5-tiadiazolidin-3-ona substituidos y composiciones y metodo de uso de los mismos.
EP0038153A3 (fr) Allergènes modifiés
EP0579765A4 (en) Method and composition for the treatment of herpes related disorders
FR2704620B1 (fr) Distributeur d'air comprimé et/ou d'autres fluides.
UA25581C2 (uk) Антиатеросклеротичний засіб
ITBO930028A1 (it) Metodo e attrezzatura per preparare carta filtro per la produzione di bustine per prodotti da infusione.
FR2713485B1 (fr) Médicament destiné à protéger et/ou à régénérer la muqueuse intestinale.
IT1228902B (it) Procedimento ed impianto per la preparazione di prodotti farmaceutici in genere.
IT1291011B1 (it) Metodo e macchina per l'impacchettamento di prodotti da forno
AU4946796A (en) Novel 1-ethyl-1,2-dihydro-2-oxo-3-methylamino-quinoxaline derivatives, their use as medicinal products and the pharmaceutical compositions comprising them